SpyGlass Pharma, Inc. SGP
Updated: 19 Jun 2026
No signal published yet
We already track SpyGlass Pharma and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow SpyGlass Pharma, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow SpyGlass Pharma free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
In June 2026, the company appointed Shannon Treviño as General Counsel and Mike Pinder as Vice President of Marketing to strengthen its leadership team. Earlier in 2026, SpyGlass reported positive 12-month Phase 1/2 results for its BIM-IOL System, which demonstrated sustained intraocular pressure control. The company is currently advancing two registrational Phase 3 trials for the system.
What Firelda Watch includes for SpyGlass Pharma, Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow SpyGlass Pharma, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow SpyGlass Pharma free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more